LANZA, MARTINA
LANZA, MARTINA
DIPARTIMENTO DI MEDICINA SPERIMENTALE
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.006 secondi).
Copper Dyshomeostasis Affects α-Synuclein Clearance Mechanisms in Parkinson’s Disease: Insights from In Vitro Models and Translational Evidence
2026-01-01 Musaro, D.; Greco, M.; Lanza, M.; Damato, M.; Maffia, M.
SGLT2 inhibitor dapagliflozin mitigates skeletal muscle pathology by modulating key proteins involved in glucose and ion homeostasis in an animal model of heart failure
2025-01-01 Conte, E; Imbrici, P; Dinoi, G; Boccanegra, B; Lanza, M; Mele, E; Riemma, Ma; Urbanek, K; Cappetta, D; De Luca, A; Berrino, L; De Angelis, A; Liantonio, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Copper Dyshomeostasis Affects α-Synuclein Clearance Mechanisms in Parkinson’s Disease: Insights from In Vitro Models and Translational Evidence | 1-gen-2026 | Musaro, D.; Greco, M.; Lanza, M.; Damato, M.; Maffia, M. | |
| SGLT2 inhibitor dapagliflozin mitigates skeletal muscle pathology by modulating key proteins involved in glucose and ion homeostasis in an animal model of heart failure | 1-gen-2025 | Conte, E; Imbrici, P; Dinoi, G; Boccanegra, B; Lanza, M; Mele, E; Riemma, Ma; Urbanek, K; Cappetta, D; De Luca, A; Berrino, L; De Angelis, A; Liantonio, A |